Longevity Health Holdings, Inc. (XAGE)
OTCMKTS · Delayed Price · Currency is USD
0.2898
0.00 (0.00%)
At close: Jan 22, 2026
Longevity Health Holdings Revenue
Longevity Health Holdings had revenue of $425.86K in the quarter ending September 30, 2025, with 1,975.46% growth. This brings the company's revenue in the last twelve months to $1.46M, up 4,337.74% year-over-year. In the year 2024, Longevity Health Holdings had annual revenue of $50.32K.
Revenue (ttm)
1.46M
Revenue Growth
+4,337.74%
P/S Ratio
0.35
Revenue / Employee
97.15K
Employees
10
Market Cap
516.35K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.32K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Sep 30, 2019 | 49.06K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Stephan Co. | 15.66M |
| CCA Industries | 7.74M |
| DSwiss | 3.50M |
| Bruush Oral Care | 2.92M |
| PURE Bioscience | 2.35M |
| Sentient Brands Holdings | 498.26K |
| Kimberly Parry Organics | 187.70K |
| Peregrine Industries | 20.88K |
Longevity Health Holdings News
- 6 months ago - Why Longevity Health Stock Is Skyrocketing Today - Benzinga
- 6 months ago - Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction - GlobeNewsWire
- 8 months ago - Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale - GlobeNewsWire
- 8 months ago - Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs - GlobeNewsWire
- 9 months ago - Longevity Health Holdings Announces Business Updates - GlobeNewsWire
- 9 months ago - Longevity Health Holdings, Inc. Announces Reverse Stock Split - GlobeNewsWire